future of compounded semaglutide FuturHealth: GLP-1s + Meals = Better Results 02/27/2025 What is compounded semaglutide and

Percentage Weight Loss Expressed as percentage of body weight: Semaglutide (diabetes doses): Average: 4-6% weight loss at 1.0mg dose At 2.0mg dose: 6-8% weight loss At weight-loss doses (Wegovy 2.4mg): ~15% weight loss Dulaglutide: Average: 2-3% weight loss at 1.5mg dose At 4.5mg dose: 3-5% weight loss Weight Loss at Maximum Doses Comparing maximum approved doses: Trulicity 4.5mg: Approximately 4.5 kg (10 lbs) or 3-5% body weight Ozempic 2.0mg: Approximately 6-8 kg (13-18 lbs) or 6-8% body weight Wegovy 2.4mg (semaglutide for weight loss): Approximately 15% body weight For patients prioritizing weight loss, semaglutide offers substantially greater benefit

Was with different company but wasn't losing weight, switched to brello and in 3 wks lost 10 pds

Fiber supplements to provide food for the microbiome and promote digestive health

Future studies will be crucial in addressing existing challenges, optimizing dosing regimens, and expanding their applications to maximize their impact on patient care

The enrollment process mirrors standard telehealth workflows but includes genetic insight options

New Rochelle residents can complete Ozari's online intake, receive physician review, and have medication shipped home with plans from $86/month on the Starter tier when clinically appropriate